125I Seed Implantation

PROCEDURE3 trials

Sponsors

Jiangxi Provincial Cancer Hospital, Li Min

Conditions

125I Seeds ImplantationHCC - Hepatocellular CarcinomaMalignant TumorsOligometastatic Disease

Phase 2

125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors

Not yet recruitingNCT07277777

Li MinMalignant Tumors

Start: 2026-01-31End: 2028-01-01Target: 90Updated: 2026-01-06

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Not yet recruitingNCT07333651

Li MinOligometastatic Disease

Start: 2026-01-31End: 2028-01-01Target: 90Updated: 2026-01-12

Unknown Phase

PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety

CompletedNCT06991907

Jiangxi Provincial Cancer Hospital125I Seeds Implantation, HCC - Hepatocellular Carcinoma

Start: 2020-01-01End: 2025-03-20Updated: 2025-05-28

Related Papers

The efficacy and safety of PD-1 inhibitors combined with <sup>125</sup>I seed implantation in treating extrahepatic metastasis of hepatocellular carcinoma.

2025-11-20